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Ether à go-go
GatingKCNH1 (EAG1) is amember of theKv family of voltage-gatedpotassium channels. However, KCNH1 channels also
show some amino-acid sequence similarity to cyclic-nucleotide-regulated channels: they harbor an N-terminal
PAS domain, a C-terminal cyclic nucleotide binding homology domain (cNBHD), and N- and C-terminal binding
sites for calmodulin. Another notable feature is the channels' high sensitivity toward oxidative modiﬁcation.
UsinghumanKCNH1expressed inXenopus oocytes andHEK 293 cellswe investigatedhowoxidativemodiﬁcation
alters channel function. Intracellular application of H2O2 or cysteine-speciﬁc modiﬁers potently inhibited KCNH1
channels in two phases. Our systematic cysteine mutagenesis study showed that the rapid and dominant phase
was attributed to a right-shift in the voltage dependence of activation, causedby chemicalmodiﬁcation of residues
C145 and C214. The slow component depended on the C-terminal residues C532 and C562. The cysteine pairs are
situated at structural elements linking the transmembrane S1 segment with the PAS domain (N-linker) and the
transmembrane channel gate S6 with the cNBH domain (C-linker), respectively. The functional state of KCNH1
channels is determined by the oxidative status of these linkers that provide an additional dimension of channel
regulation.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The ether à go-go (EAG) gene encodes a voltage-dependent potassium
channel and was ﬁrst cloned from Drosophila [1] during analysis of
mutations affecting membrane excitability. Subsequent molecular
studies and sequence comparison resulted in the formation of a dis-
tinct potassium channel group: the EAG family. The EAG family now
consists of 3 subfamilies: EAG, EAG-related gene (ERG), and EAG-like
K+ channel (ELK). The mammalian EAG subfamily comprises of two
members, termed EAG1 (KCNH1, KV10.1 [2,3]) and EAG2 (KCNH5,
KV10.2 [4,5]). The pore-formingα-subunit of KCNH1 channels contains
a core domain resembling that of other voltage-dependent K+ channels
with six transmembrane segments (S1–S6) including a charged S4
voltage sensor, and functional channels are suggested to be homotetra-
meric. In addition, the channel contains large cytosolic amino and
carboxyl termini. In its N terminus, KCNH1 harbors a Per-ARNT-Simis[2-nitrobenzoic acid]); DTNP,
SET, [2-(trimethylammonium)
atoethyl methanethiosulfonate
fax: +49 3641 9 39 56 52.
.H. Heinemann).
rights reserved.(PAS) dimerization domain [6] and a calmodulin-binding motif [7].
The C terminus contains a cyclic nucleotide binding homology domain
sequence (cNBHD) and two additional calmodulin/S100B binding
motifs [8,9].
KCNH1 is widely expressed in the central nervous system, proba-
bly participating in neuronal signaling. In situ hybridization studies
have detected KCNH1 transcripts predominantly in the hippocampus,
cerebral cortex, dopaminergic neurons of basal ganglia, and olfactory
bulb and granular layer of the cerebellum of adult rats [4,10–12].
KCNH1 channels may also be involved in sensory functions of auditory
transduction and phototransduction. Rat KCNH1 mRNA has been
detected in the organ of Corti and in the ﬁbrocytes of the spiral liga-
ment [13]. In situ hybridization of bovine retinal tissue localized two
splice variants of the KCNH1 channel transcript to photoreceptors
and retinal ganglion cells [14]. In rod photoreceptors, KCNH1 channels
probably underlie an outward K+ current, named IKx, which stabilizes
the dark resting potential and accelerates the voltage response to small
photocurrents [15]. KCNH1 channels are also essential for induction of
human myoblast differentiation and fusion [3,16]. Apart from their
physiological function, KCNH1 channels were found abnormally up-
regulated in many cancer cells while absent from the corresponding
healthy tissues. First observations of this aberrant expression included
cell lines derived from breast carcinoma (MCF7, EFM-19 and BT-474),
cervical carcinoma (HeLa), neuroblastoma (SH-SY5Y), and melanoma
(IGR1) [17–19]. Later studies directly conﬁrmed the overexpression
of KCNH1 in tumor tissue of a large variety of human cancers [20].
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by a plethora of posttranslational modiﬁcations, including oxidation of
certain amino acid residues such as cysteines [21–24]. The functional
activity of human ether à go-go-related gene 1 (hERG1, KCNH2) potassi-
um channels is efﬁciently diminishedwhen cellular ROS levels increase,
e.g. in response to hyperglycemia [25,26]. We recently identiﬁed a cys-
teine residue (C723) in the cytosolic C terminus of KCNH2 as a major
determinant of this oxidation sensitivity. Oxidation of this residue by
H2O2 or by thiol-speciﬁc reagents resulted in channel inhibition and
faster deactivation kinetics [27]. Given the vital function of KCNH2
channels in the control of cardiac action potential repolarization
[28], this illustrates the potentially profound impact of seemingly
mild modiﬁcations on channel proteins. Intriguingly, a splice variant
of KCNH2 (hERG1b) that shows speciﬁcally high expression in the
heart [29] was found to be less sensitive to oxidative modiﬁcation
[27].
In this study we ask if KCNH1 channels are also subject to ROS-
mediated functional modulation. We show that KCNH1 channel
function is tightly controlled by each two cysteine residues situated
in the structural elements linking the cytosolic N-terminal (N-linker)
and C-terminal (C-linker) domains to the transmembrane domain,
which harbors the channel gate and pore.
2. Materials and methods
2.1. Chemicals
DTNB (5, 5′-dithio-bis[2-nitrobenzoic acid]), DTNP (2,2′-dithio-
bis [5-nitropyridine]), and DTT (dithiothreitol) were obtained from
Sigma (Taufkirchen, Germany); MTSET ([2-(trimethylammonium)
ethyl] methane thiosulfonate bromide) and MTSES (2-sulfonatoethyl
methanethiosulfonate sodium salt) were from Toronto Research Che-
micals (North York, ON, Canada). All reagents were freshly prepared
in intracellular solution prior to each experiment and stored at 4 °C
and used within 20 min.
2.2. Channel constructs and site-directed mutagenesis
The following channel types were used in this study: human EAG1
(hEAG1, KCNH1), rat Kv1.1 (rKv1.1, KCNA1), and humanKv1.5 (hKv1.5,
KCNA5).
Within the Xenopus oocyte expression vector KCNH1-pGEMHE,
the following point mutants of KCNH1 were generated by overlap-
extension methods as described previously [8] and veriﬁed by sequenc-
ing: C50A, C67A, C128A, C145A, C214A, C303A, C532A, C541A, C562A,
C575A, C592A, C631A, C640A, C794-804-817-853A, Cys-less N (C50-
67-128-145-214A), Cys-less T (C303A-C357V-C368V), and Cys-less C
(C532-541-562-575-592-631-640-794-804-817-853A). Cysteine resi-
dues were replaced with alanine except for the residues in the S5
segment: C357V, C368V. In the background of a mutant lacking all
cysteines from the cytosolic termini (Cys-less NC), individual cysteine
residues (A128C, A145C, A214C, A532C, and A562C) were reintroduced
to determine their individual impact.
2.3. Channel expression in Xenopus oocytes and HEK 293 cells
Capped mRNAwas synthesized in vitro using the mMessage mMa-
chine kit (Ambion, Austin, TX, USA). Oocytes were surgically removed
from the ovarian tissue of Xenopus laevis that had been anesthetized
by immersion in ice water/tricaine according to the local animal
care program. The oocytes were defolliculated, and healthy stage V
and VI oocytes were isolated and microinjected with 50 nl of a solu-
tion containing channel wild-type or mutant mRNA. The removal of
the vitelline membrane was carried out by enzymatic treatment as
described by Wang [30]. Electrophysiological measurements were
performed 2–4 days after mRNA injection.KCNH1 in themammalian cell expression vector pcDNA3 (Invitrogen,
Darmstadt, Germany) was transiently expressed in HEK 293 cells using
Superfect transfection kit (Qiagen, Hilden, Germany). Dynabeads
(Deutsche Dynal GmbH, Hamburg, Germany) were used for visual iden-
tiﬁcation of individual cells, cotransfectedwith CD8. Electrophysiological
recordings were performed 2–3 days after transfection.2.4. Electrophysiological measurements
Ionic currents were recorded using the inside-out or whole-cell
conﬁguration at room temperature using an EPC-9 patch-clamp am-
pliﬁer operated with PatchMaster software (both HEKA Elektronik,
Lambrecht, Germany). Inside-out patch-clamp experiments were car-
ried out with Xenopus oocytes; macroscopic currents were measured
using aluminum silicate glass pipettes with resistances of about 1 MΩ.
The intracellular solutions contained (in mM): 100 K-aspartate, 10
EGTA, 15 KCl, 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) (pH 7.2 or 8.0 with KOH). The extracellular solution contained
(in mM): 103.6 Na-aspartate (for recordings under symmetrical K+
conditions 103.6 K-aspartate), 11.4 KCl, 1.8 CaCl2, 10 HEPES (pH 7.2
with NaOH). Solution changes in patch-clamp experiments were
performed using a multi-channel perfusion system in which the
patch was placed directly in the center of streaming solution. Whole-
cell voltage-clamp experiments were carried out with transiently
transfected HEK 293 cells. Patch pipettes from borosilicate glass
with resistances of 0.9–2 MΩ were used. Pipette solution contained
(in mM): 130 KCl, 2.56 MgCl2, 10 EGTA, 10 HEPES (pH 7.4, KOH);
bath solution: 135 NaCl, 5 KCl, 2 CaCl2, 10 HEPES (pH 7.4, NaOH).
Cells with series resistance above 5 MΩ were discarded; the series
resistance was compensated for by more than 70%.
Voltage dependence of channel opening was measured by applying
200-ms depolarizations in steps of 10 mV. The resulting maximal
current, subjected to a p/6 leak correction procedure, was plotted
as a function of test voltage and described with a Hodgkin–Huxley
approach involving four activation gates and a linear single-channel
current–voltage relationship:
I Vð Þ ¼ Γ V−Erevð Þ
Imax
1þ e− V−Vmð Þ=km 4
ð1Þ
with the linear conductance Γ, the reversal potential Erev, the half-
maximal activation voltage per gate Vm, and the corresponding slope
factor km.2.5. Non-stationary noise analysis
Non-stationary noise analysis was performed from sets of at least
200 successive current sweeps elicited by depolarizations to −20, 0,
20, 40, and 80 mV. Ensemble variances were compiled from differ-
ences of neighboring records [31] and variance–current plots of the
activating current phases were simultaneously ﬁt for all voltages (V)
according to Starkus et al. [32] to yield the single-channel current
i(V), the maximal open probability Po(V), and the number of active
channels. Data ﬁts were always performed simultaneously for control
and DTNB-modiﬁed patches for all voltages available constraining N,
the total number of active channels. This procedure particularly ensured
reliable estimates of low Po values at lowdepolarization and uponDTNB
application.
Data were analyzed with FitMaster (HEKA Elektronik) and IgorPro
(WaveMetrics, Lake Oswego, OR, USA). Data are presented as mean±
SEM (n=number of independent measurements). P values refer to
two-sided Student's t-tests with unequal variances.
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Fig. 1. Intracellular cysteines of KCNH1 are susceptible to oxidative modiﬁcation. (A)
Superposition of current traces recorded from KCNH1-transfected HEK 293 cells at
40 mV before (black) and 200 s after (gray) extracellular application of 100 μM DTNB,
20 μM DTNP, and 1 mMH2O2, respectively. (B) Mean time courses of normalized currents
at 40 mV for the application of DTNB, DTNP, and H2O2; substances in concentration as in
(A) were applied at time zero. (C) Superposition of current traces at 40 mV from inside-
out patches of Xenopus oocytes expressing the indicated channel types before (black)
and 100 s after (gray) cytosolic application of 100 μM DTNB. (D) Mean time courses
of normalized inside-out patch currents at 40 mV for the indicated channel types
upon application of 100 μM DTNB at time zero. Relative remaining current after
100 s was 29±1% for KCNH1 (n=5, gray circles); for rat KCNA1 (open circles) and
human KCNA5 (black circles) current amplitude did not signiﬁcantly decrease (P>0.05).
(E) Superposition of inside-out patch KCNH1 current traces before (black) and 100 s
after (gray) application of 300 μMMTSET and 100 μMMTSES, respectively. Straight lines
connect the data points in B and D; data are mean±SEM with n in parentheses. Holding
potential was−80 mV in all cases.
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3.1. KCNH1 channels are particularly sensitive to intracellular cysteine
modiﬁcation
KCNH2 channels are tightly regulated by the redox status of intracel-
lular cysteine residues [27]. We thus tested the sensitivity of the non-
inactivating close relative KCNH1 on cysteine-modifying substances.
KCNH1 was expressed in HEK 293 cells and currents were recorded in
the whole-cell conﬁguration in response to repetitive depolarizations
to 40 mV. Extracellular application of the thiol-modifying reagent
DTNB (100 μM), a hydrophilic poorly membrane permeable compound
that modiﬁes proteins based on the principle of thiol-disulﬁde exchange
reaction, only slightly increased the KCNH1-mediated outward current
(Fig. 1A, B). In contrast, extracellular application of 20 μM of DTNP,
a lipophilic membrane permeable thiol-modifying reagent, caused
rapid and complete inhibition of macroscopic KCNH1 current (Fig. 1A,
B). Treatment with the slowly membrane permeable physiological
oxidant hydrogen peroxide (H2O2, 1 mM) only induced slow KCNH1
channel inhibition with 30±8% remaining current after exposure of
200 s (n=6, Fig. 1A, B). These results suggest that, similar to KCNH2,
intracellular cysteines are responsible for the profound alteration of
the KCNH1 channel activity by DTNP or H2O2.
Unlike for KCNH2 channels, however, KCNH1 channels are readily
investigated in inside-out patches taken from Xenopus oocytes because
in the excised patch conﬁguration only a small degree of current loss
(rundown) is observed. We therefore compared the effects of 100 μM
DTNB when applied to the intracellular side of the membrane. As
shown in Fig. 1C and D, KCNH1 currents were reduced by 72±3%,
while the voltage-gated potassium channels KCNA1 and KCNA5 were
resistant to DTNB treatment. The sensitivity of KCNH1 was not speciﬁc
for DTNB because also thiol-modiﬁers MTSET (positively charged) and
MTSES (negatively charged) strongly diminished KCNH1 currents
(Fig. 1E; remaining current after 160 s: 18±1% for 100 μMMTSES and
10±1% for 300 μM MTSET). Further experiments were performed
with DTNB, in particular because DTNB is a relatively small molecule
and the effect on the channel could be reversed with the reducing
agent DTT (see below, Fig. 2B).
3.2. Time course of DTNB effect on KCNH1 is indicative of multiple targets
The time course of channel modiﬁcation by 20 μM DTNB on the cy-
tosolic sidewas analyzed inmore detail using symmetrical K+ solutions
and a pulse protocol assaying for channel activation at −40, 40, and
100 mV (Fig. 2A). At each of the three voltages the peak current elicited
was decreased by DTNB application in a biphasic manner (Fig. 2B).
Wash with control saline did not recover the current, but application
of 3 mMDTT restored the currents almost completely strongly suggest-
ing that DTNB action is mediated by cysteine-speciﬁc modiﬁcation
(Fig. 2C).
Analysis of the current decay as a function of time revealed two expo-
nential components, characterized by two time constants (τfast, τslow,
Fig. 2D)with the respective amplitudes (afast, aslow, Fig. 2E): for example,
at 40 mV τfast=12.8±2.0 s, τslow=369±91 s, with a relative fast frac-
tion (afast/(afast+aslow)) of 62±5.9% (n=5). At higher DTNB concen-
tration (100 μM) the kinetics was about 2–3 fold faster. In addition, the
reaction was slower at stronger depolarization (100 mV vs −40 mV;
Pb0.01) suggesting that the DTNB effect on hEAG1 channels depends
on the voltage and/or the channel conformational change.
3.3. DTNB alters the gating of KCNH1 channels
The observation that DTNB decreases KCNH1 currents could be
interpreted to indicate that DTNB is a simple pore blocker. However,
several lines of evidence collectively show that DTNB is rather a gating
modiﬁer of KCNH1 channels. For example, intracellular application of20 μM DTNB slowed the activation kinetics at 40 mV (from to 4.9±
0.8 ms to 11.5±1.1 ms), and accelerated the deactivation kinetics at
−120 mV (from 1.88±0.15 ms to 1.06±0.06 ms) (Fig. 3B). The volt-
age dependence of channel activationwas analyzed bymeasuring chan-
nel opening in symmetrical K+ solutions and the normalized maximal
currents were ﬁt with Eq. (1). As shown in Fig. 3C and D, DTNB reduced
not only the current, but also the remaining current displayed altered
voltage dependence: DTNB shifted the half-activation voltage (Vm)
from −65.7±3.6 mV to −49.3±0.9 mV and the slope factor (km)
from 29.5±1.9 mV to 40.9±5.6 mV (n=5).
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Fig. 2. Time course of DTNB modiﬁcation of KCNH1 channel function. (A) Current
traces from an inside-out patch with KCNH1 channels at the holding potential of
−120 mV, pulsing to the indicated voltages (for 50 ms each) under control conditions
(black) and upon application of 20 μM DTNB for the indicated incubation times (gray).
(B) Time course of DTNB-mediated (20 μM) current rundown with double-exponential
ﬁts superimposed followed by wash with control saline at three voltages (open circles,
100 mV, gray circles, 40 mV, and triangles, −40 mV). Pulse interval was 10 s. (C) Time
course of KCNH1 current at 40 mV with application of 20 μMDTNB and wash with saline
containing 3 mM DTT. (D and E) Analysis of inhibitory kinetics: time constants (D) and
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KCNH1 molecules expressed at the cell surface (N), the single-channel
current amplitude (i), and the open probability (Popen) of the channel.
In principle, a change in any of these three components of the macro-
scopic current could account for the effect of thiol reagents. To differen-
tiate between changes in single-channel conductance and channel Popen,
non-stationary noise analysis was performed in the inside-out patch
clamp conﬁguration. As illustrated in Fig. 3E and F, application of
20 μM DTNB to the intracellular side of KCNH1 resulted in a substantial
decrease in Popen (e.g. at 0 mV from 45.5±0.6% to 0.6±0.4% and at
80 mV from 64.8±0.6% to 14.3±1.4%) and only a mild reduction of
the unitary current size assuming a constant number of active channels.
This ﬁnding shows that DTNB is not a pore blocker but rather affects
channel gating, effectively reducing the probability of channel opening.
The effect of DTNB is weaker at stronger depolarization such as if
voltage-dependent conformational changeswould counteract the action
of the thiol modiﬁer.3.4. Identiﬁcation of critical cysteines responsible for thiol-dependent
alteration of channel function
To gain structural insight into the thiol-dependence of KCNH1
channel function we used site-directed mutagenesis to identify critical
cysteine residues. As illustrated in Fig. 4A, a KCNH1 α-subunit harbors
19 cysteine residues, 3 located in the predicted transmembrane seg-
ments, 5 in the N-terminal, and 11 in the C-terminal domains; the latter
two domains are facing the intracellular side. We thus examined the
effects of DTNB on KCNH1 constructs in which one or more cysteines
were mutated to alanine except for two that were mutated to valine.
When all 19 cysteines were replaced, channels expressed poorly and
were difﬁcult to study.
Constructs lacking 3 cysteines in the transmembrane region (Cys-
less T), 5 cysteines in the N terminus (Cys-less N), 11 cysteines in the
C terminus (Cys-less C), or lacking 16 cysteines in both N and C ter-
minus (Cys-less NC) expressed well and generated macroscopic cur-
rents. When cysteine residues within the predicted transmembrane
region were mutated, the resulting channels retained their sensitivity
towards 20 μM cytosolic DTNB (not shown), while the construct
lacking all cysteines in the N- and C-terminal domains (Cyc-less
NC) was not affected at all by DTNB (Fig. 4B, C). In Cys-less N, the
fast component of the DTNB effect was abolished; the remaining
slow block developed with a time constant (τslow) of 404±73 s. In
Cys-less C, only a rapid current block with a time constant (τfast) of
20±7 s was observed (Fig. 4B, C). Comparison with the two time
constants obtained for the wild type (τfast=12.8 s, τslow=369 s)
suggests that cysteine residues in the N terminus must be responsible
for the rapid effect and cysteine residues in the C terminus for the
slow effect of DTNB.
From this observation it appears that N-terminal cysteines play a
major role in DTNB-mediated channel inhibition. To assess the func-
tional importance of the ﬁve cysteine residues in the N terminus,
each was mutated to alanine and assayed for the fractional current
remaining after DTNB treatment. Mutants C145A and C214A showed
the weakest response to DTNB with ~65% of the current remaining
after 200-s application of 100 μM DTNB (not shown), here operation-
ally deﬁned as DTNB sensitivity. From the analysis of half-activation
voltage (Vm), mutants C145A and C214A exhibited a smaller shift
when exposed to DTNB (11 and 6 mV, respectively), while the shifts
in Vm of KCNH1 wild type, C50A, C67A, and C128A were 29, 15, 16,
and 19 mV, respectively. Based on this graded response, we generated
the double mutant C145-214A; this showed a markedly diminished
sensitivity towards DTNB, leaving only a minor slow component
(Fig. 5A, B). Interestingly, the slow onset of DTNB-induced inhibition
only occurred with a substantial delay, presumably indicative of the
involvement of multiple targets in this response. In addition, the
voltage-dependence of channel activation, characterized by Vm and
km, was resistant to DTNB (Fig. 5C).
A similar approach was followed for the C-terminal cysteines. Out
of all individual C-to-A substitutions, none strongly affected the sen-
sitivity towards DTNB, most likely because of the presence of the
sensitive N-terminal residues C145 and C214. Given the conservation
of the major cytosolic domains of KCNH1 channels such as C-linker
and CNG-binding domain within the EAG family, KCNH1 channels
may share some similarity to KCNH2 channels. A study from our
group [27] has found that C723 and C740 of KCNH2 are responsible
for oxidative modiﬁcation and mutation of these cysteine residues
rendered the KCNH2 channel insensitive to reactive oxygen species.
The homologous positions in KCNH1 are C532 and C562. Combination
of these mutations (C532-562A) resulted in channels largely resem-
bling the DTNB sensitivity of Cys-less C, namely only displaying a
rapid but saturating response to DTNB (Fig. 5A, B). Unlike mutant
C145-214A, the DTNB impact on voltage dependence was not affected
by mutation C532-562A, i.e. Vm and km of the resulting channels were
shifted like the wild type (Fig. 5C). Combination of both construct,
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much as in Cys-less NC (Fig. 5).
Thus the mutagenesis results collectively show that residues C145
and C214 are important for the rapid component of the DTNB effect
and, once thiol-modiﬁed, result in a shift in the voltage dependence
of channel activation. The C-terminal residues C532 and C562, located
in the C-linker region, play a minor role, being responsible for a slow,
but complete loss of channel function.
Elimination of cysteines and observation of an altered response to
a thiol modiﬁer not necessarily mean that a particular residue is a tar-
get of thiol modiﬁcation. We thus applied an additional approach by
starting with the DTNB-insensitive Cys-less NC construct and reintro-
duced individual cysteines. As shown in Fig. 6A, C, introduction of
C128 did not induce DTNB sensitivity, serving as a negative control.
Introduction of either C145 or C214 reestablished part of the rapid
DTNB response. Likewise, reintroduction of C532 and, particularly, C562
resulted in a slow component of DTNB-medicated current reduction(Fig. 6B, C). Both sets of experiments support the aforementioned
that, indeed, C145/C214 in the N-terminal domain and C532/C562
in the C-terminal domain are of prime importance of the functional
state of KCNH1 channels.
To test if the identiﬁed cysteine residues are only of relevance for
KNCH1 function when modiﬁed with DTNB, we subjected inside-out
patches with wild-type channels and mutant C145-214-532-562A to
H2O2 and the thiol modiﬁers MTSET and MTSES. As illustrated in
Fig. 7, in all cases modiﬁcation resulted in a biphasic loss of channel
function in the wild type while the mutations eliminated the channel's
sensitivity toward oxidative modiﬁcation.
3.5. State dependence of KCNH1 thiol modiﬁcation
Data shown thus far indicated that the effect of DTNB on KCNH1
channels depends on the membrane voltage. In addition, DTNB-
mediated alteration of the gating parameters is associated with
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idues apparently have an impact on channel gating, the channel's
conformational state could, in turn, affect the accessibility of such
residues. We therefore measured the effect of 20 μM DTNB on KCNH1
channels in inside-out patches during repetitive pulsing to 40 mV at
an interval of 20 s; between these pulses the holding voltage was either
set to−80 mVor 20 mV, thus keeping the channelmost of the time in adeactivated or activated conﬁguration, respectively. As shown in Fig. 8A,
DTNB inhibited the channels signiﬁcantly more strongly when the
membrane potential was held at−80 mV indicating that critical cyste-
ines aremore accessible and/or reactivewhen the channel is in a resting
conformation. Since the protocol for the “20 mV condition” involved
sojourns around resting voltage for about 500 ms to acquire p/n
pulses, channels were not kept in an activated state all of the time.
We therefore assayed the effect of DTNB on channels, either held at
−120 or 20 mV for 100 s, without pulsing. As shown in Fig. 8B, C,
current inhibition was substantially greater under resting conditions
compared to 20 mV (P>0.01) illustrating a strong use- or voltage
dependence of channel modiﬁcation.4. Discussion
4.1. Structure–function implications
The identiﬁcation of four critical cysteine residues not only revealed
the major target sites of oxidative modiﬁcation in KCNH1, but also
provides new insights into the dynamic interplay of functional chan-
nel domains. The four targets of oxidation fall into two functional
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C562), respectively. Notably, the amino acids conferring oxidation sen-
sitivity are not located in any of the deﬁned protein domains, such as
the PAS domain, the cyclic nucleotide binding homology domain or
the transmembrane helices (Fig. 4A), but in linker regions for which
no precise functional roles have been attributed thus far.
Oxidative modiﬁcation of cysteines in the N-linker is characterized
by rapid kinetics and by a resulting right shift in voltage dependence.
Thus, both sites must be well exposed to the attack by DTNB, H2O2,
and MTS reagents and are most likely in a polar environment. Unlike
chemical modiﬁcation of the C-linker cysteines, modiﬁcation of the
N-terminal oxidation targets did not result in complete current loss,
regardless of the oxidant concentration or the time of exposure. The
modiﬁed channels are still active, but functionally altered. Oxidation of
a mutant channel lacking the C-terminal target sites (C532A·C562A) in-
duced a prominent shift inactivation of about 20 mV, while mutagenesis
of the N-terminal residues (C145A·C214A) resulted in a similar shift
(Fig. 5C). Thus, complete oxidation of the N-linker sites shifts the voltage
dependence of activation and therefore results in markedly lower
current amplitudes at the test potential of 40 mVwithout completely
impairing channel function.
By contrast, oxidation of critical cysteines in the C-linker was char-
acterized by slower kinetics; this reduced reactivity is indicative of a
more buried and hydrophobic localization in the overall structure.
Despite this slower kinetics, the effect of oxidation here was moredramatic, ultimately leading to complete loss of function. Thus, the
impact of C-linker oxidation is either an extremely large shift in the
voltage dependence of activation to the positive direction or it must
involve other mechanisms leading to channel dysfunction. The latter
is supported by a mild impact of mutagenesis of the critical residues
(C532A·C562A) on half-maximal activation voltage (Fig. 5C).
Several molecular mechanisms are conceivable to provide a mech-
anistic link between cysteine modiﬁcation and loss of current. (I) Most
straightforwardly one could postulate a direct interference of modiﬁed
residues with the ion permeation pathway. Given the cytoplasmic
location of the critical cysteines this is unlikely and non-stationary
noise analysis of DTNB-modiﬁed KCNH1 channels (Fig. 3 E, F) directly
ruled out alterations in the single-channel conductance as cause of cur-
rent loss. (II) Channel exposure to oxidative agents might be suspected
to either break or induce disulﬁde bridges between the critical cysteine
residues. However, in this case for each functional pair of cysteines one
should expect that mutagenic replacements of either of the sites or of
both sites have equal functional effects unless intersubunit disulﬁde
bonds are involved. This is not supported by our data, as cysteinemuta-
genesis had additive protective effects. (III) More complex scenarios
might be summarized as “allosteric mechanisms”, assuming that the
modiﬁcations inﬂuence endogenous interactions within functional
channel domains. Such an assumption appears to be plausible from
a study by Stevens et al. [33] where they observed a structural and
functional interaction between PAS and cNBHD of the KCNH1 channel.
DTNBmight induce its inhibitory effect by interferingwith the cross talk
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and the cNBHD regions of CNGA1 channels has been previously demon-
strated by Gordon et al. [34]. In summary, the functional similarities
between N-linker cysteines on the one hand and C-linker cysteines
on the other hand imply that each pair of cysteines affects a distinct
functional aspect of the channel.
Neither for the cytosolic N terminus nor for the C terminus of the
KCNH1 protein a clear function has been deﬁned yet, but mutagenesis
studies imply that they have principally opposing effects on channel
opening. At least the proximal half of the C terminus, including C-
linker and cNBHD is essential for the formation of functional channels.
A systematic deletion study by Chen and coworkers [35] showed that
removal of the distal C terminus by introduced stop codons in the C-
linker (Q477X or R521X) or closely behind the cNBHD (N673X or
E722X) of the rat KCNH1 protein abolished the formation of electro-
physiologically functional channels. If we therefore assume that the
cNBHD takes part in the process of channel opening, any allosteric
control mechanism most likely involves the C-linker as a coupler be-
tween this domain and the cytosolic end of S6 as the channel's probable
gate structure. In this context, it is tempting to speculate that oxidation
of cysteines in the C-linker disrupts this essential interaction between C
terminus and gate. Interestingly, the critical role of cysteines in the
C-linker of KCNH1 parallels the oxidation sensitivity of the C-linker
residue C723 in the human KCNH2 channel [27]. Just like in
KCNH1, presence of the C-linker and the cNBH domain in KCNH2
channels is required for active channel formation and oxidation of
C723 results in current reduction and faster channel deactivation—
more rapid channel closure. Likewise, a recent high-resolution structure
of a zebraﬁsh KCNH paralog (ELK) demonstrated the importance of the
C-linker structure for intersubunit interaction and, hence, presumably
the coordination of channel gating events [36].
In contrast to the requirement of the C terminus for the formation
of a functional KCNH1 channel, complete deletion of the N terminus
(Δ2-190) from KCNH1 still results in functional voltage-gated K+
channels [7,37]. Compared to the wild type, such truncated channels
open at very negative voltages, with a shift of the half-activation volt-
age of about−70 mV [7]. Apparently, the function of the N terminus
in KCNH1 is not to promote channel opening, but rather to stabilize aclosed state that is only opened upon depolarization. The underlying
mechanism is unknown, but a physical interaction between residues
in the distal N terminus and the S4-S5 linker was strongly suggested
by mutagenesis studies in rat KCNH1 [37]. More recent structural
analyses revealed that the S4–S5 linkers in voltage-gated K+ channels
[38,39] as well as in voltage-gated Na+ channels [40] form short heli-
ces that contact the cytosolic end of the S6 helices and link movements
in the voltage sensor to movements in S6 to open or close the gate. If
the S4-S5 helix forms a “cuff” that constricts the gate [40], it is conceiv-
able that interaction of the N terminus in KCNH1 with the S4–S5 helix
stabilizes the closed conformation of this cuff, shifting the activation
voltage to more positive potentials. In this context, the observed
right shift of the half-activation voltage upon cysteine oxidation in
the N-linker suggests that one function of the N terminus is not dis-
turbed through oxidation, but rather augmented. Cysteine oxidation
by DTNB is a relatively dramatic modiﬁcation adding an aromatic ring
structure and a negative charge to the site. Interestingly, a more subtle
modiﬁcation, the mutagenic replacement of alanine for cysteine
(C145A, C214A), introduced a very similar right shift in voltage depen-
dence as the oxidation. Quite remarkably, the major component of
channel inhibition by DTNB, i.e. a component associated with modiﬁca-
tion of C145/C214 in the N terminus, was strongly dependent on the
channel's conformational state (Fig. 8). Depolarization-induced channel
opening effectively protected these sites frommodiﬁcation arguing that
in KCNH1 channelsmovement of the voltage-sensor elements has a pro-
found impact on the structure of the cytosolic N-terminal domains.
In summary, cysteine oxidation in KCNH1 can induce current reduc-
tion by twomechanisms: oxidation in the N terminus augments a right
shift in voltage dependence that is physiologically conferred by the N
terminus. By contrast, oxidation in the C-linker most likely disturbs an
essential mechanical link between the cNBHD and the S6 helix.
4.2. Physiological role of ROS-mediated channel regulation
Elevated levels of physiological ROS generation are known to play a
key role in aging and many neuronal disorders such as in Alzheimer's
disease and Parkinson's disease. Oxidative stress generated during
these conditions induces progressive loss of neuronal function,
resulting in gradual decrease of motor and non-motor function (see
review [41]). One of such ROS-induced changes could possibly be
due tomodiﬁcation of K+ channels that are responsible for repolarizing
the action potential. In support of this idea, Cai and Sesti [42] showed
that in the nematode Caenorhabditis elegans oxidation of K+ channels
by ROS is a major mechanism underlying the loss of neuronal function.
This observation supports an assertion that K+ channels controlling
neuronal excitability and survival might provide a common, functional-
ly important substrate for ROS in aging in mammals. In fact, a recent
study by deOliveira et al. [11] showed that global brain ischemia altered
the gene expression of KCNH1 (eag1) and KCNH5 (eag2) in the hippo-
campus. These observations suggest a signiﬁcant functional role of EAG
channels in synaptic plasticity processes in response to ischemic insult.
The localization of KCNH1 channels in the brain may permit selective
neuronal modulation by redox reactions, conferred by the presence
of speciﬁc cysteine residues. In hippocampal neurons, ROS-mediated in-
hibition of KCNH1 current would shorten the after-hyperpolarization,
resulting in hyperexcitability. In physiological levels of ROS, mild oxida-
tive stress as occurring during increased neuronal activity may act
through a positive feedback by reducing K+ channel activity and
thereby augmenting neuronal ﬁring.
A growing body of evidence suggests that increased generation of
ROS and an altered redox status is observed in cancer cells [43]. In addi-
tion, the participation of ion channels in cancer and apoptosis is increas-
ingly documented [44]. However, to date, no studies have provided
information regarding the inﬂuence of ROS on ion channels in cancer
cells. KCNH1 channels are ectopically expressed in many human cancer
cell lines and its expression induces their progression and proliferation.
1195N. Sahoo et al. / Biochimica et Biophysica Acta 1818 (2012) 1187–1195The speciﬁc blockade of KCNH1 by monoclonal antibodies inhibited
tumor cell growth both in vitro and in vivo [45]. Thus, cysteine oxidation
of KCNH1 by ROS in cancer cells is expected to inhibit cancer cell growth.
Further studies are needed to advance our knowledge of redox regula-
tion of these ion channels in cancer cells in situ.
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